IGI Laboratories, Inc. (AMEX: IG)

IGI Laboratories, Inc. develops, manufactures, and markets topical formulations in the United States. The company sells its generic topical pharmaceutical products under the IGI label. It also develops, manufactures, fills, and packages topical semi-solid and liquid products for branded and generic pharmaceutical customers, as well as for over-the-counter (OTC) and cosmetic markets. The company’s products are used in various applications from cosmetics and cosmeceuticals to the prescription treatment of conditions, such as dermatitis, psoriasis, and eczema.
Take a look at the 1-year chart of IGI (AMEX: IG) below with added notations:

IG rallied from February into December before finally stalling at around $11. The stock has hit that $11 mark again several times this month. If IG can retest the $11 level once more (red) the stock may finally look to break through. A close above that resistance would also constitute a new 52-week high.
The Tale of the Tape: IG has a 52-week resistance at $11. The possible long position on the stock would be on a breakout above that level with a stop placed under it.
Please share this article